Table 1.
HIV-1 Env Epitope | Antibody | Challenge virus (route) | Antibody dose (mg/kg) | No. of animals (infected/total) | Reference |
---|---|---|---|---|---|
CD4 binding site | b12 | SHIVSF162P4 (vaginal) | 25 | 0/4 | (Parren et al., 2001) |
1 | 4/4 | ||||
SHIVSF162P3 (vaginal) | 25 | 1/9 | (Hessell et al., 2007) | ||
VRC01 | SHIVSF162P3 (vaginal) | 20 | 0/4 | (Ko et al., 2014) | |
SHIVSF162P3 (rectal) | 20 | 0/4 | (Ko et al., 2014) | ||
SHIVSF162P3 (oral) | (Hessell et al., 2009a) | ||||
5 | 1/5 | ||||
SHIVBaL.P4 (rectal) | 20 | 0/6 | (Ko et al., 2014) | ||
0.3 | 16/22 | (Ko et al., 2014) | |||
SHIVAD8EO (rectal) | (Shingai et al., 2014) | ||||
20 | 2/2 | ||||
VRC01LS | SHIVSF162P3 (rectal) | 20 | 1/6 | Unpublished | |
SHIVBaL.P4 (rectal) | 0.3 | 5/12 | (Ko et al., 2014) | ||
SHIVBG505 (rectal) | 20 | 0/4 | Unpublished | ||
VRC07–523LS | SHIVBaL.P4 (rectal) | (Rudicell et al., 2014) | |||
0.05 | 4/4 | ||||
SHIVSF162P3 (rectal) | 20 | 0/6 | Unpublished | ||
N6LS | SHIVBG505 (rectal) | 20 | 0/4 | Unpublished | |
2.5 | 2/4 | ||||
3BNC117 | SHIVAD8EO (rectal) | (Shingai et al., 2014) | |||
1 | 2/2 | ||||
SHIV327c (rectal) | (Julg et al., 2017) | ||||
2 | 3/3 | ||||
V1V2 | PGDM1400 | SHIV325C (rectal) | 2 | 0/5 | (Julg et al., 2017) |
0.08 | 3/4 | ||||
CAP256.VRC26.25LS | SHIV325C (rectal) | 2 | 0/4 | (Julg et al., 2017) | |
0.08 | 0/4 | ||||
PG9 | SHIVBaL.P4 (rectal) | 20 | 2/6 | (Ko et al., 2014) | |
0.3 | 6/6 | ||||
V3-glycan | PGT121 | SHIVSF162P3 (vaginal) | 5 | 0/5 | (Moldt et al., 2012) |
0.2 | 2/5 | ||||
SHIVAD8EO (rectal) | 20 | 0/2 | (Shingai et al., 2014) | ||
0/2 | |||||
0.2 | 2/2 | ||||
SHIV327c (rectal) | (Julg et al., 2017) | ||||
2 | 1/3 | ||||
PGT126 | SHIVSF162P3 (vaginal) | 10 | 0/5 | (Moldt et al., 2016) | |
0.4 | 4/5 | ||||
SHIVSF162P3 (rectal) | 10 | 1/4 | (Moldt et al., 2016) | ||
0.4 | 4/4 | ||||
10–1074 | SHIVAD8EO (rectal) | 20 | 0/2 | (Shingai et al., 2014) | |
1 | 2/2 | ||||
High mannose glycan | 2G12 | SHIVSF162P3 (vaginal) | 40 | 2/5 | (Hessell et al., 2009b) |
MPER | 4E10 | SHIVBa-L (rectal) | 50 | 0/6 | (Hessell et al., 2010) |
2F5 | SHIVBa-L (rectal) | 50 | 0/6 | (Hessell et al., 2010) | |
10E8 | SHIVBaL.P4 (rectal) | 20 | 0/6 | (Ko et al., 2014) | |
0.3 | 3/6 |